Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 20, 2017

Primary Completion Date

May 21, 2018

Study Completion Date

May 21, 2018

Conditions
Coronary Artery Disease
Interventions
DEVICE

Excimer Laser Coronary Atherectomy

Excimer Laser Coronary Atherectomy (ELCA ®) uses the high energy, monochromatic light beam to alter or dissolve (vaporize) the plaque without damaging the surrounding tissue. Fiber-optic catheters are used to deliver this light beam. For endovascular applications, Xenon Chloride excimer laser is used and its fiber-optic catheter has multiple small fibers, rather than just a few large fibers, in order to be flexible enough to navigate in the arterial tree.

Trial Locations (5)

100050

Lilavati Hospital and Research Centre, Bandra

122001

Global Health Private Limited, Medanta - The Medicity, Gurgaon

160011

Escorts Heart Institute & Research Centre Limited, New Delhi

560069

Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore

Unknown

All Indian Institute of Medical Sciences (AIIMS), New Delhi

All Listed Sponsors
collaborator

CBCC-VIBGYOR Research Pvt. Ltd.

OTHER

lead

Spectranetics Corporation

INDUSTRY

NCT03284229 - Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD | Biotech Hunter | Biotech Hunter